Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-09

Clinical Trial Update: Intermuscular Coherence as a Biomarker for ALS

View source ↗

Summary

This clinical trial entry notes the recruitment status for a study evaluating intermuscular coherence as a biomarker in amyotrophic lateral sclerosis at the Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Chicago | Conditions: Amyotrophic Lateral Sclerosis | Status: RECRUITING